FDA inspection
Cytovance Biologics Inc.: FDA inspection ending Jun 17, 2026
FDA inspection 1322570 · Voluntary Action Indicated (VAI) · Oklahoma City, OK
Key facts
| Inspection ID | 1322570 |
|---|---|
| Firm | Cytovance Biologics Inc. |
| FEI number | 3006341547 |
| Address | 800 Research Pkwy Ste 200 |
| City | Oklahoma City |
| State | OK |
| ZIP | 73104 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Jun 17, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data